Records containing: Hematologic Malignancies
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-03-26Modular Phase II Study to Link Targeted Therapy to Patients With Pathway Activated Tumors: Module 4 - LGX818 for Patients With BRAFV600 Mutated Tumors
-
CLINICAL_TRIALS study record update · 2021-03-17A Phase 1 Study of Duvelisib in Patients With Advanced Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2021-02-17Optimal Dosing of Vancomycin in an Adult Population of Hemato-oncology: a Nomogram Based on a Bayesian Population Model to Predict Initial Dosage of Vancomycin
-
CLINICAL_TRIALS study record update · 2021-02-16Phase I Study of CA-18C3 in Subjects With Advanced Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2021-02-16A Prospective Randomized Trial Examining Low- or Intermediate-Dose Cyclophosphamide for Hematopoietic Stem Cell Mobilization in Patients With a Hematologic Malignancy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-11-23Non-Myeloablative Chemotherapy Followed by HLA-Matched Related Allogeneic Stem Cell Transplantation for Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2020-10-05A Phase I/II Safety Study of Planned BPX-501 T Cell Infusion After Partially Mismatched, Related, HSCT in Adults With Advanced Hematologic Malignances at High Risk for Relapse
-
CLINICAL_TRIALS study record update · 2020-09-22Biospecimen Procurement for Immunological Landscape Studies Following Hematopoietic Cell Transplantation
-
CLINICAL_TRIALS study record update · 2020-09-11A Phase I, Open-label, Dose-escalation Study of the Safety and Pharmacokinetics of HMPL-523 in Patients With Relapsed or Refractory Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2020-07-28Impact of the Comprehensive Geriatric Assessment on the Quality of Life of Elderly Onco-hematologic Patients' Candidates for Complex Antitumoral Therapies: Clinical and Biological Correlatives
-
CLINICAL_TRIALS study record update · 2020-06-25Phase I Study to Assess the Tolerability and Efficacy of Nivolumab as Single Agent to Eliminate Minimal Residual Disease and Maintain Remission in Patients With Hematologic Malignancies After Allogeneic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2020-02-25Partially HLA Mismatched (Haploidentical) Allogeneic Bone Marrow Transplantation for Patients With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2020-01-07Three-arm Clinical Trial for Patients With Hematologic Malignancies and Mismatched Donors - Haploidentical, 1 Antigen Mismatch Related or Unrelated, and Matched Unrelated Donor (MUD)- Using a T-cell Replete Allograft and High-dose Post-transplant Cyclophosphamide
-
CLINICAL_TRIALS study record update · 2020-01-06Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and Graft-versus-host Disease in Allogeneic Hematopoietic Cell Transplantation for High-risk Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2019-10-14Phase I/II Study of Low-Dose Cyclophosphamide, Tumor Associated Peptide Antigen-Pulsed Dendritic Cell Therapy and Low Dose GM-CSF, As Consolidation Treatment in Patients With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2019-08-21Umbilical Cord Transplantation for the Elderly Population
-
CLINICAL_TRIALS study record update · 2019-08-08A Phase I, Open Label, Dose Escalation Study of Oral Administration of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies
-
CLINICAL_TRIALS study record update · 2019-07-16A Controlled Study of Stem Cell Transplantation Medical Home Care Compared to Standard Hospital Care
-
CLINICAL_TRIALS study record update · 2019-06-18Modular Phase II Study to Link Targeted Therapy to Patients With Pathway Activated Tumors: Module 6 - BGJ398 for Patients With Tumors With FGFR Genetic Alterations
-
CLINICAL_TRIALS study record update · 2019-03-08A Phase I, Multicenter, Open-Label, Dose-Escalation and Expansion, Safety, Pharmacokinetic, Pharmacodynamic, and Clinical Activity Study of Orally Administered AG-881 in Patients With Advanced Hematologic Malignancies With an IDH1 and/or IDH2 Mutation
-
CLINICAL_TRIALS study record update · 2019-02-22Assessing Performance Status in Cancer Patients Using Cardiopulmonary Exercise Testing and Wearable Data Generation: A Prospective Observational Study
-
CLINICAL_TRIALS study record update · 2019-02-15Exercise Capacity, Physical Activity Level and Quality of Life in Newly Diagnosed Hematologic Malignant Patients
-
CLINICAL_TRIALS study record update · 2019-01-23Sequential Infusion of Unmanipulated Donor Lymphocytes and Cytokine Induced Killer (CIK)Cells After Allogeneic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2019-01-18UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELLS (UC-MSC) FOR THE TREATMENT OF SEVERE (GRADE III-IV) STEROID-RESISTANT GRAFT VERSUS HOST DISEASE (GvHD): A PHASE I/II TRIAL
-
CLINICAL_TRIALS study record update · 2018-12-11A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of Atezolizumab (MPDL3280A) Administered Intravenously as a Single Agent to Patients With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies